NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Why Rocket Pharmaceuticals shareholders are filing suit over adverse event risks in RP-A501 A class action lawsuit claims Rocket Pharmaceuticals misled investors about the safety and effectiveness of its gene therapy. Find out what’s at stake. byPallavi MadhirajuAugust 3, 2025